Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients (Rainbow)
The main goal of this trial is to "evaluate the practical modalities and performance of the EULAR-RAID score in patients with rheumatoid arthritis who have been prescribed etanercept as part of usual medical practice."
Study Type: Interventional
Age/Gender Requirement: 18 years+ (male/female)
Sponsor: Wyeth
Researchers are looking for patients with RA who meet the 1987 ACR Revised Criteria for Rheumatoid Arthritis, can store injectable tests at 2-8 degrees Celsius, and are able and willing to "self-inject ETN or have a designee who can do so to participate in this phase IV clinical trial. The main goal is to "evaluate the practical modalities and performance of the [European League against Rheumatism Rheumatoid Arthritis Impact of Disease] EULAR-RAID score in patients with rheumatoid arthritis who have been prescribed etanercept as part of usual medical practice."
